Axxcess Wealth Management LLC Has $3.57 Million Stock Holdings in Danaher Co. (NYSE:DHR)

Axxcess Wealth Management LLC lifted its position in Danaher Co. (NYSE:DHR) by 25.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,418 shares of the conglomerate’s stock after buying an additional 3,165 shares during the period. Axxcess Wealth Management LLC’s holdings in Danaher were worth $3,567,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the business. BKM Wealth Management LLC acquired a new stake in shares of Danaher in the fourth quarter valued at approximately $27,000. Wetzel Investment Advisors Inc. acquired a new position in shares of Danaher during the 4th quarter worth about $29,000. OFI Invest Asset Management bought a new stake in Danaher during the third quarter worth about $30,000. Rakuten Securities Inc. bought a new stake in shares of Danaher during the 4th quarter worth approximately $36,000. Finally, Financial Connections Group Inc. bought a new position in shares of Danaher in the 4th quarter valued at about $41,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In related news, Director Teri List sold 3,289 shares of the stock in a transaction dated Tuesday, February 6th. The stock was sold at an average price of $248.32, for a total transaction of $816,724.48. Following the sale, the director now owns 19,726 shares of the company’s stock, valued at approximately $4,898,360.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Teri List sold 3,289 shares of the stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $248.32, for a total value of $816,724.48. Following the sale, the director now owns 19,726 shares in the company, valued at $4,898,360.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Alan G. Spoon sold 708 shares of the company’s stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $243.58, for a total transaction of $172,454.64. Following the completion of the transaction, the director now owns 116,202 shares of the company’s stock, valued at $28,304,483.16. The disclosure for this sale can be found here. Insiders have sold 107,273 shares of company stock valued at $26,813,819 in the last 90 days. 11.10% of the stock is currently owned by company insiders.

Danaher Stock Up 0.6 %

Shares of Danaher stock traded up $1.54 during trading hours on Friday, reaching $248.38. The company’s stock had a trading volume of 1,787,817 shares, compared to its average volume of 2,914,990. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.51 and a current ratio of 1.85. The stock’s fifty day simple moving average is $248.48 and its two-hundred day simple moving average is $232.27. The company has a market capitalization of $183.97 billion, a P/E ratio of 42.10, a P/E/G ratio of 3.80 and a beta of 0.83. Danaher Co. has a one year low of $182.09 and a one year high of $259.00.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.20. Danaher had a return on equity of 11.43% and a net margin of 16.78%. The company had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.62 billion. During the same quarter last year, the company earned $2.36 earnings per share. The company’s revenue for the quarter was down 2.6% on a year-over-year basis. On average, research analysts forecast that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 26th. Investors of record on Thursday, March 28th were issued a $0.27 dividend. This is an increase from Danaher’s previous quarterly dividend of $0.24. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.43%. The ex-dividend date of this dividend was Wednesday, March 27th. Danaher’s payout ratio is 18.31%.

Analyst Ratings Changes

DHR has been the topic of a number of recent analyst reports. Royal Bank of Canada boosted their target price on Danaher from $254.00 to $282.00 and gave the stock an “outperform” rating in a report on Wednesday, January 31st. Robert W. Baird raised their target price on shares of Danaher from $259.00 to $271.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 24th. Barclays lifted their target price on shares of Danaher from $260.00 to $270.00 and gave the stock an “equal weight” rating in a report on Wednesday, April 24th. Raymond James raised their price objective on shares of Danaher from $240.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. Finally, Bank of America increased their target price on Danaher from $258.00 to $270.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 24th. Six equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $267.31.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.